Literature DB >> 7225741

The social, emotional and financial implications of adjuvant chemotherapy in breast cancer.

C S McArdle, K C Calman, A F Cooper, A V Hughson, A R Russell, D C Smith.   

Abstract

The incidence and severity of toxicity, the extent of emotional disturbance and cost of adjuvant chemotherapy were assessed in patients with early breast cancer randomized to receive either radiotherapy, chemotherapy (CMF) or radiotherapy followed by chemotherapy. Nausea and vomiting occurred in 85 per cent of patients receiving chemotherapy and contributed significantly to distress. Over one-third of patients required a wig or developed mucosal ulceration. Nevertheless, most patients were able to return to work during treatment. Leucopoenia was more commonly encountered in those patients who received radiotherapy prior to chemotherapy. Twelve months after mastectomy, psychiatric morbidity was present in 13 of 34 patients receiving chemotherapy with or without radiotherapy, compared with only 1 of 18 receiving radiotherapy alone. Anxiety was common in both groups. This trend was still present 6 months after the completion of chemotherapy. The cost of chemotherapy is discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7225741     DOI: 10.1002/bjs.1800680413

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  5 in total

1.  Controversies in the medical management of breast cancer.

Authors:  I E Smith
Journal:  Postgrad Med J       Date:  1985-02       Impact factor: 2.401

Review 2.  Adjuvant chemotherapy for early breast cancer.

Authors:  I E Smith
Journal:  Br Med J (Clin Res Ed)       Date:  1983-08-06

Review 3.  Review of general surgery 1981.

Authors:  H Ellis
Journal:  Postgrad Med J       Date:  1982-06       Impact factor: 2.401

4.  The cost of breast cancer recurrences.

Authors:  S F Hurley; R M Huggins; R D Snyder; J F Bishop
Journal:  Br J Cancer       Date:  1992-03       Impact factor: 7.640

5.  The development of a method for assessing the quality of life of cancer patients.

Authors:  P J Selby; J A Chapman; J Etazadi-Amoli; D Dalley; N F Boyd
Journal:  Br J Cancer       Date:  1984-07       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.